Translate Bio, Inc. TBIO
$ 37.36
0.0%
Translate Bio, Inc. Financial Statements 2011-2024 | TBIO
Annual Financial Statements Translate Bio, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.23 B | 387 M | 153 M | - | - | - | - | - | - | - |
Shares |
51.4 M | 51.4 M | 26.9 M | - | - | - | - | - | - | - |
Net Income |
-53.8 M | -113 M | -97.4 M | -66.4 M | -26.7 M | - | - | - | - | - |
Revenue |
139 M | 7.8 M | 1.42 M | - | - | - | - | - | - | - |
EBITDA |
2.53 M | -92.5 M | -76.4 M | -41.8 M | -26.1 M | - | - | - | - | - |
Operating Expenses |
146 M | 105 M | 80.6 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
35.9 M | 28.6 M | 22.6 M | 14.3 M | 11.1 M | - | - | - | - | - |
All numbers in USD currency